Watchlist Price Alert

InVivo Therapeutics Corp... (NVIV)

NASDAQ: NVIV · Real-Time Price · USD

0.32

-0.17 (-34.43%)

At close: Feb 12, 2024, 9:00 PM

InVivo Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-10.49M	-9.89M	-9.07M	-11.83M	-23.42M	-26.75M	-23.44M
Depreciation & Amortization	445K	372K	329K	322K	91K	395K	553K
Stock-Based Compensation	159K	315K	215K	268K	618K	4.11M	5.06M
Other Working Capital	-608K	230K	-543K	132K	-1.04M	88K	880K
Other Non-Cash Items	159K	315K	215K	667K	11.62M	188K	306K
Deferred Income Tax	-159K	-315K	-215K	n/a	n/a	2.31M	-593K
Change in Working Capital	-596K	354K	-1M	259K	-1.22M	65K	1.37M
Operating Cash Flow	-10.48M	-8.85M	-9.53M	-10.31M	-12.31M	-19.68M	-16.74M
Capital Expenditures	-160K	-77K	-41K	-12K	-65K	-65K	-107K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	-8.26M	-18.92M
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	19.83M	12.52M
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-160K	-77K	-41K	-12K	-65K	11.51M	-6.51M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	7.96M	8.51M	22.46M	268K	15.88M	-383K	29.79M
Financial Cash Flow	7.96M	8.51M	22.46M	268K	15.88M	-383K	29.79M
Net Cash Flow	-2.68M	-422K	12.89M	-10.06M	3.5M	-8.55M	6.54M
Free Cash Flow	-10.64M	-8.93M	-9.57M	-10.33M	-12.38M	-19.75M	-16.85M